Abo T, Cooper M, Balch C
J Exp Med. 1982; 155(1):321-6.
PMID: 7054358
PMC: 2186573.
DOI: 10.1084/jem.155.1.321.
Abo T, Miller C, Gartland G, Balch C
J Exp Med. 1983; 157(1):273-84.
PMID: 6848618
PMC: 2186891.
DOI: 10.1084/jem.157.1.273.
Hashimoto G, Wright P, Karzon D
Infect Immun. 1983; 42(1):214-8.
PMID: 6604697
PMC: 264545.
DOI: 10.1128/iai.42.1.214-218.1983.
Yanagawa E, Uchida A, Micksche M
Cancer Immunol Immunother. 1984; 17(1):1-6.
PMID: 6563940
PMC: 11039075.
DOI: 10.1007/BF00205490.
Kimber I, Moore M, Howell A, Wilkinson M
Cancer Immunol Immunother. 1983; 15(1):32-8.
PMID: 6553505
PMC: 11039102.
DOI: 10.1007/BF00199459.
The biology of the human natural killer cell.
Roder J, Pross H
J Clin Immunol. 1982; 2(4):249-63.
PMID: 6292259
DOI: 10.1007/BF00915064.
Recognition specificities, development and possible biological function of natural killer cells in the mouse. II. Changes in NK recognition during ontogeny and ageing, and examination of role of environment in controlling the expressed recognition....
Gorczynski R, Harris J, Kennedy M, MacRae S, Chang M
Immunology. 1984; 53(4):731-43.
PMID: 6149997
PMC: 1454893.
Particular features of cell-mediated immunity in patients with anaplastic gliomas. A comparison with kidney and bladder cancer patients.
Servadei F, Parente R, Bucci M, Beltrandi E, Tognetti F, GAIST G
J Neurooncol. 1983; 1(4):327-32.
PMID: 6088720
DOI: 10.1007/BF00165716.
Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis.
Arico M, Nespoli L, Maccario R, Montagna D, Bonetti F, Caselli D
Arch Dis Child. 1988; 63(3):292-6.
PMID: 3355209
PMC: 1778784.
DOI: 10.1136/adc.63.3.292.
Natural killer, lymphokine-activated killer and interferon-gamma producing activities of peripheral blood- and regional lymph node-mononuclear cells in 23 cases of colorectal cancer.
Matsunaga H, Kuwahara Y, Kusugami K, Morise K, Shimokata K
Gastroenterol Jpn. 1988; 23(5):527-33.
PMID: 3145895
DOI: 10.1007/BF02779484.
Impaired neonatal natural killer-cell activity to herpes simplex virus: decreased inhibition of viral replication and altered response to lymphokines.
Leibson P, Douvas G, Hayward A
J Clin Immunol. 1986; 6(3):216-24.
PMID: 3013922
DOI: 10.1007/BF00918701.
Cell-mediated cytotoxic activity of spleen cells from patients with gastric carcinoma.
Akiyoshi T, Koba F, Arinaga S, Wada T, Tsuji H
Jpn J Surg. 1988; 18(2):164-71.
PMID: 2969062
DOI: 10.1007/BF02471426.
Cell-mediated cytotoxic activity of regional lymph node cells from patients with gastric carcinoma.
Koba F, Akiyoshi T, Arinaga S, Wada T, Tsuji H
Jpn J Surg. 1987; 17(2):83-90.
PMID: 2957537
DOI: 10.1007/BF02470646.
Relationship of the distribution of Leu-2+ cells with suppressor cell activities in the spleen and lymph-nodes from gastric cancer.
Toge T, Seto Y, Kuroi K, Yamada H, Aratani K, Fujita T
Jpn J Surg. 1987; 17(2):72-7.
PMID: 2957536
DOI: 10.1007/BF02470644.
Abnormal expansions of granular lymphocytes: reactive lymphocytosis or chronic leukemia? Case report and literature review.
Gastl G, Rumpold H, Kraft D, Gattringer C, Schuler G, Margreiter R
Blut. 1986; 52(2):73-89.
PMID: 2936412
DOI: 10.1007/BF00321070.
Cytotoxicity and clinical application of activated NK cells.
Lotzova E
Med Oncol Tumor Pharmacother. 1989; 6(1):93-8.
PMID: 2786121
DOI: 10.1007/BF02985229.
Interleukin 2 and interferon-gamma activities of mononuclear cells from regional lymph nodes in patients with gastric cancer.
Kusugami K, Matsuura T, Kawase T, Ina K, Matsunaga H, Kuwahara Y
Gastroenterol Jpn. 1990; 25(3):306-13.
PMID: 1972685
DOI: 10.1007/BF02779443.
